Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Persistent RAV's after Viekira Pak


Guru

Status: Offline
Posts: 3398
Date:
Persistent RAV's after Viekira Pak
Permalink  
 


Hi all,

In a recent thread, retreating with Harvoni was mentioned for any treatment failures on Viekira Pak. There is a question mark over this.

At the recent EASL Meeting, a paper was presented dealing with the persistence of RAV's after failed Viekira Pak treatment. This is of particular interest for the Genotype 1a's.

The paper lists the RAV's found in treatment failures. As expected, the RAV's at the NS-3 site declined over time, and only 9% of RAV's were present at EOT +48 weeks. However, RAV's at NS-5A persisted and 96% were still present after EOT +48 weeks. From previous studies, these RAV's to Ombitasvir are similar to the RAV's associated with Ledipasvir.

What we need now is a similar paper detailing the RAV's associated with Harvoni treatment failures.

Thankfully the number of treatment failures will be small.

http://www.natap.org/2015/EASL/EASL_38.htm



__________________

Geno 1b, IL28B CT,  x3 prior relapser,  ex-cirrhotic, 75 yo, did 48 weeks with Victrelis/Peg./Riba.  VL 1.28m at start, UNDET. at 8 ,12 ,16 ,24 ,30  and 48 weeks.  EOT 15 Feb 2013 , UNDET. at EOT + 28 weeks. SVR!  Still Undet. at EOT +5 years

Malcolm

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.